Process

What Is the Ideal Cost-Benefit Analysis?

What Is the Ideal Cost-Benefit Analysis?

Two researchers propose a simpler way to perform cost-benefit analysis.

A New Way to Measure Industry-Level Regulation

A New Way to Measure Industry-Level Regulation

New dataset provides researchers new opportunities for analyzing regulatory impacts.

Why We Need to Measure Regulation

Why We Need to Measure Regulation

Answering key questions about regulation requires better data.

Improving Regulatory Agenda-Setting

Improving Regulatory Agenda-Setting

Penn Program on Regulation workshop focuses on key factors shaping regulatory agendas.

Professor Coglianese to Lead New Initiative on Regulatory Excellence

Professor Coglianese to Lead New Initiative on Regulatory Excellence

Penn receives $1.2 million from Alberta Energy Regulator to lead Best-in-Class Regulator Initiative.

Predicting Regulatory Delay

Predicting Regulatory Delay

New model aims to predict how long it takes rules to be published after they clear OIRA review.

What are the Effects of State Voter Identification Laws?

What are the Effects of State Voter Identification Laws?

A recent GAO report investigates how ID requirements impact voter turnout.

There is More to Mandatory Disclosure than Meets the Eye

There is More to Mandatory Disclosure than Meets the Eye

“Targeted transparency” can help achieve regulatory and regulated entity goals.

Supreme Court Regulatory Cases to Watch

Supreme Court Regulatory Cases to Watch

In its upcoming term, Supreme Court will decide key regulatory issues.

Rethinking States’ Role in Federal Rulemaking

Rethinking States’ Role in Federal Rulemaking

By understanding key tradeoffs, federal agencies can enhance state participation in the regulatory process.

The Advantages of Private Certification Over Government Regulation

The Advantages of Private Certification Over Government Regulation

Private certification may better achieve regulatory goals than governments and regulatory agencies.

When a State Agency is Not a State Actor

When a State Agency is Not a State Actor

The U.S. Supreme Court will decide when a state agency is immune from federal antitrust law.